Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2026 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2026 Earnings Call Transcript April 29, 2026Agios Pharmaceuticals, Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:AGIO’
10 Oversold Small Cap Stocks to Buy Now
In this article, we will take a look at some of the most oversold small-cap stocks that currently offer attractive upside to investors. On April 18, stocks in the U.S.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2025 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2025 Earnings Call Transcript February 12, 2026Agios Pharmaceuticals, Inc. beats earnings expectations.
Agios Pharmaceuticals, Inc. (AGIO): A Bull Case Theory
We came across a bullish thesis on Agios Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on AGIO.
Agios (AGIO) Gets 18.6% Boost from Aqvesme OK
Agios Pharmaceuticals soared by 18.63 percent on Wednesday to close at $29.17 apiece after securing the approval of the Food and Drug Administration (FDA) for anemia treatment...
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) ranks among the most oversold biotech stocks to invest in. On November 20, Leerink Partners upgraded Agios Pharmaceuticals, Inc.
9 Oversold Biotech Stocks to Invest In
Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and healthcare.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript October 30, 2025Agios Pharmaceuticals, Inc. beats earnings expectations.
Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is a commercial-stage biopharmaceutical company focused on therapies for rare diseases, particularly in cellular metabolism.
11 Cheap Biotech Stocks to Buy According to Hedge Funds
Mizuho's Jared Holz appeared on CNBC's "Closing Bell Overtime" on July 8 to talk about whether the biotech industry is prepared for a breakthrough.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2025 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2025 Earnings Call Transcript July 31, 2025Agios Pharmaceuticals, Inc. misses on earnings expectations.
Agios Pharmaceuticals, Inc. (AGIO) Backed by TD Cowen for Mitapivat’s Market Potential
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is among the best NASDAQ stocks under $50 to buy.
10 Best NASDAQ Stocks Under $50 to Buy
In this era where everyone is striving for the best, whether it be something in daily life or technology, the stock market is no exception.
H.C. Wainwright Maintains a Buy Rating on Agios Pharmaceuticals (AGIO), Reduces PT
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, Analyst Emily Bodnar of H.C.
10 Best Small-Cap Growth Stocks to Buy According to Analysts
On March 26, Gabelli Funds released its small-cap 2025 outlook, highlighting the valuation discounts backing the small caps and the tailwinds from the macroeconomic backdrop.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Agios’ First Quarter 2025 Conference Call. At this time all participants are in a listen-only mode.
10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
10 Best Small-Cap Stocks to Buy Now
The S&P 500 index has reached its all-time highs, achieving returns of over 20% for two second consecutive years post-COVID.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' Fourth Quarter 2024 Conference Call.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential
On December 30, MJP Wealth Advisors chief investment officer Brian Vendig appeared on Yahoo! Finance's Catalysts to discuss the potential outlook of small cap stocks in 2025.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' Third Quarter 2024 Conference Call.
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript August 1, 2024Agios Pharmaceuticals, Inc. misses on earnings expectations.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios’ First Quarter 2024 Conference Call.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Agios Pharmaceuticals Incorporated quarter three 2023 earnings conference call.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Agios’ Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to Agios Fourth Quarter and Year-End 2022 Conference Call. At this time, all participants are in a listen-only mode.
Should I Avoid Agios Pharmaceuticals Inc (AGIO)?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Here is What Hedge Funds Think About Agios Pharmaceuticals Inc (AGIO)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is AGIO Stock A Buy or Sell?
With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Is AGIO A Good Stock To Buy Now?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Have Never Been This Bullish On Agios Pharmaceuticals Inc (AGIO)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Agios Pharmaceuticals Inc (AGIO) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Standing By Agios Pharmaceuticals Inc (AGIO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Were Buying Agios Pharmaceuticals Inc (AGIO) Before The Coronavirus
We hate to say this but, we told you so.
These Hedge Funds Cashed Out Of Agios Pharmaceuticals Inc (AGIO) Too Early
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Agios Pharmaceuticals Inc (AGIO) Is Burning These Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Agios Pharmaceuticals Inc (AGIO) Going to Burn These Hedge Funds?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Alibaba, Cisco, Agios Pharmaceuticals and More: Why These Stocks Are in the Spotlight
Although it is rapidly approaching 13F season and traders are closely watching oil stocks due to the rising Middle East tensions, several stocks such as Alibaba Group Holding...
Did Hedge Funds Drop The Ball On Agios Pharmaceuticals Inc (AGIO)?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions...
Hedge Funds Are Selling Agios Pharmaceuticals Inc (AGIO)
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Hedge Fund and Insider Trading News: Steven Cohen, Carl Icahn, Beigene Ltd (BGNE), Brooks Automation, Inc (BRKS), and More
After a cohort of hedge fund veterans called it quits last year, a trio of established managers are prepping to fill their shoes in 2018 by starting firms with at least a billion...
Here is What Hedge Funds Think About Agios Pharmaceuticals Inc (AGIO)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital
At Insider Monkey, we track some 750 hedge funds and other institutional investors.
This Healthcare Fund Just Had A Huge Q3: Here’s How
The mainstream media likes taking shots at hedge funds because they are easy targets.
Hedge Fund Resource Center
